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Considerable  emphasis has been placed on the role of acid-proteases within lyso- 
somes of polymorphonuclear leukocytes (PMNL) in the pathogenesis of allergic  and 
other forms of tissue injury (1, 2). We reported previously (3) that a cationic protein- 
containing fraction of PMNL lysosomes, extracted by weak mineral acid and precipi- 
tated by ethanol at a 20 per cent (v/v) concentration, produced inflammatory changes 
in the microcirculation of rat and rabbit mesentery. However, such cationic protein 
fractions of leukocyte granules are reportedly free of acid-proteases (4)  and other 
hydrolases (3)  normally associated with intact leukocyte lysosomes.  This apparent 
discrepancy led us to suggest alternative mechanisms of action of lysosomal cationic 
protein fractions in local tissue injury reactions and to propose that a part, at least, 
of the inflammatory changes  induced by whole granule preparations might be medi- 
ated independently of their protease content. 
In the  course of these earlier investigations it was found that the  cationic 
protein fraction, in addition to causing adhesion and emigration of leukocytes, 
also produced a marked increase in vascular permeability to circulating Evan's 
blue dye when the protein was applied topically onto rat mesentery or when it 
was injected intracutaneously into rat skin. However, in vitro  tests using iso- 
lated smooth muscle preparations failed to reveal any kinin-like, serotonin, or 
histamine activity in this extract  (3).  Further  studies have now been carried 
out  on the mechanism of action  of crude extracts of PMNL  lysosomes, and 
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also of the cationic protein isolated from these granules,  upon vascular perme- 
ability in skin and cremasteric muscle of the rat. The present report will present 
evidence which suggests  that  the  early increase  in vascular permeability pro- 
duced  in rat  tissues  by PMNL  lysosomes is  caused  by vasotropic agents  dis- 
charged  from  tissue  mast  cells  and  not  by protease  activity of  the  granules. 
This  effect  is  due  to  a  mastocytolyfic  agent  present  in  the  cationic  protein 
fraction of PMNL  lysosomes. 
Materials and Methods 
Preparation  of Leukocyte Lysosome Fractions.--Rabbit  peritoneal  exudate  polymorpho- 
nuclear leukocytes (PMNL)  were collected and  their granules isolated by the technique of 
Cohn and Hirsch (5).  Superuates of frozen-thawed granules and  cationic protein-containing 
extracts of the granules were prepared by previously described techniques  (3) except that in 
the  present  studies  dialysis  of the fractions  was  carried  out  against  sodium  bicarbonate- 
buffered, mammalian-Ringer's balanced salt solution at pH 7.2. Protein content of the various 
fractions was determined by the method of Lowry (6), with crystalline bovine serum albumin 
as a standard. 
General Method  of Permeability  Tests in Rat Skin.--The  method  employed to  evaluate 
permeability effects in rat skin was essentially similar to that described by Miles and Wilhelm 
(7).  Materials to be tested were injected in a  volume of 0.05  ml, intracutaneously,  into the 
shaved abdominal skin of rats  (males,  Sprague-Dawley strain, 250 to 350 gm body weight) 
anesthetized  with  sodium  pentobarbital  (nembutal,  Abbott  Laboratories,  North  Chicago, 
Ill.). In each of the test animals at least two separate sites were prepared  at each dose of 
test agent. Either immediately or at varying times after the intracutaneous administration of 
test substances,  Evan's blue dye was injected intravenously as a  1 per cent solution in iso- 
tonic saline and at a dose of 0.4 ml per 100 gm of body weight. Animals were regularly sacri- 
ficed 20 minutes after dye injection and  the abdominal skin was reflected for examination 
of the undersurface.  The grade of edema in the injected skin site was estimated according 
to the diameter and color intensity (visual observation) of the dye accumulated in the tissues. 
General Method of Permeability Tests in Cremaster Muscle of the Rat.--Permeability effects 
in rat  cremasteric  muscle  were studied  using the carbon-labelling technique  described  by 
Majno (8).  Aliquots of 0.05  ml of the materials to be tested were injected subcutaneously 
into the scrotal sac just over the mid-ventral surface of the testis. Either immediately or at 
varying times after the injection of test substances,  carbon suspension  (pelikan Cl1-1431a, 
Gunther Wagner,  Germany)  was injected intravenously  (0.1 mi per  100 gm body weight). 
Animals were sacrificed  1 hour  after injecting the carbon  suspension,  and  the testes were 
placed briefly in 10 per cent formalin. The muscle was then dissected free of other structures, 
stretched, and pinned on dental wax, fixed in formalin for an additional 24 hours, cleared in 
xylene, and mounted in glycerine-jelly for low power light microscopic observation.  In this 
test, vessels whose permeability has been abnormally increased by the subcutaneous injection 
of test material appear blackened by carbon particles which have passed between endothelial 
cells.  Furthermore,  the characteristic topography of the microcirculation in rat  cremasteric 
muscle (8) readily permits identification of the type of vessel (venule,  capillary, or arteriole) 
most affected by the test agent. 
Assay of Mastocytolytic Activity in Vitro.--The effect of leukocyte granule fractions upon 
rat mast cells in ~itro was assayed according to the technique described by Norton (9). Briefly, 
this involved incubation of pieces of rat mesentery in Ringer-Locke glucose solution buffered 
with bicarbonate to pH 7.45 and containing varying concentrations of either leukocyte frac- A.  JANO~F~'~ S.  SCHAEFER,  J.  SCHERER,  AND  M.  A.  BEAN  843 
tions or known mastocytolytic agents such as compound 48/80  (Burroughs Wellcome and 
Co.,  Inc., Tuckahoe,  New York).  Thirty minutes of incubation at room temperature was 
routinely employed in all tests; and, incubation in Ringer-Locke alone was always included 
as a control for spontaneous mast cell rupture. Following the period of incubation, the tissues 
were fixed in 10 per cent formalin containing 0.1 per cent toluidine blue, dehydrated in ace- 
tone, cleared in xylene, mounted in permount (Fisher Scientific Co., Fairlawn, New Jersey), 
and examined microscopically for the enumeration of intact vs.  disrupted mast cells. 
Details of methodology which were varied according to the needs of each experiment are 
described in the appropriate sections of the Results. 
TABLE I 
Time Course of Vascular Permeability Change Produced by PMNL Lysosomes in Rats 
Test agent 
Lysosomal cationic 
protein (20 per cent 
ethanol fraction) 
Extract  of  frozen- 
thawed granules 
Test site/dose 
(/~g protein) 
Skin 
(10) 
Cremaster 
(20) 
0 min.* 
++++ 
(lO) 
++ 
(6) 
Reaction/No. of rats in test 
Skin 
(lO) 
Cremaster 
(30) 
++++ 
(10) 
++ 
(4) 
1  30 rain.*  60 mln.*/120  rain.* 
trace  0  0 
(6)  (6)  (6) 
0 
(4) 
+  0  0 
(6)  (6)  (6) 
0 
(4) 
180 mill.' 
o 
(6) 
0 
(6) 
Scale o/response: 
++++  (skin), raised, intensely blue wheal, 12 to 15 mm diameter. 
+  (skin), fiat, pale-blue, uneven reaction, 5 mm or less in diameter. 
++  (cremaster),  postcapillary  collecting veunles show carbon deposits  over area 10 to 
15 mm in diameter. 
0 (no reaction), no blue dye grossly visible (skin) or carbon deposits microscopically visible 
(cremaster). 
* Elapsed  time between intracutaneous  (skin) or subcutaneous  (cremaster)  injection  of 
test agent and intravenous  injection of Evan's blue (skin) or carbon suspension (eremaster). 
RESULTS 
Time  Course  of  the  Permeability  Change  Produced  in  Skin  and  Cremaster 
Muscle of Rats by PMNL  Lysosomes.--Table  I  shows  that  the  permeability 
changes induced in skin  and  cremaster  muscle  of rats  by single injections  of 
PMNL  lysosomes  (both extracts  of frozen-thawed granules and cationic pro- 
tein  fractions)  are  acute,  transient  changes  which  disappear  rapidly. 
When animals were injected intravenously with Evan's blue either immedi- 
ately  before  or  after  intracutaneous  application  of  lysosomal  materials,  an 
intense  exudation  of plasma-bound  dye developed,  rapidly  reaching  a  maxi- 
mum diameter of 12 to 15 mm in 15 or 20 minutes.  However, when dye was 844  IN'FL.A MMA.TORY  MECHANISM 
injected 30 or 60 minutes after the lysosomal fractions,  only trace reactions 
occurred  (pale, incomplete  staining); and, at 2 and 3 hours after injection of 
materials into the skin, no discernible exudation of dye was observed  except 
at the finely circumscribed  point of passage  of the needle into the skin (see 
Table I). The absence of dye exudation at later intervals was not exclusively 
the result of mechanical interference  with local blood flow following engorge- 
ment of tissue spaces with fluid during the early phase of the reaction. This was 
shown by the fact that injection of 2/zg of histamine into the same skin sites 
previously treated with lysosome fractions produced  typical histamine blueing 
reactions  at these sites in the later time-groups  (2 and 3 hours). 
When animals  received  an intravenous injection of carbon suspension im- 
mediately after  subcutaneous  application  of  lysosomal  materials  over  the 
cremaster muscle  (frozen-thawed  granules  or cationic  protein), a  widespread 
blackening of venules developed in the muscle, in a pattern identical with that 
produced in this tissue by similar injections  of histamine. However, if carbon 
suspension  was  administered 2 hours  after injection of lysosomal  materials 
over the muscle, no labelling of vessels could be discerned (see Table I). Again, 
it could  be  shown  that potential vascular reaction was  still  present  in  the 
cremaster  at this time, since reinjection of the scrotal  sac with the standard 
dose of histamine just before the administration of carbon produced a normal 
venular-labelling  pattern  in  animals  that had  been  treated with lysosomal 
materials 2 hours earlier. 
Although the doses of lysed granule protein and cationic protein shown in 
Table I  were the ones most frequently employed in permeability tests, other 
experiments  have shown  that strong permeability changes  (2+  and 3+  re- 
actions, see Table I) can be produced by as little as  2 #g of protein in the skin 
and  10 #g in cremaster  muscle. 
Mastocytolytic Activity of PMNL Lysosomes in Vitro.--In view of the acute, 
transient nature of the vascular permeability change produced in rat tissues by 
PMNL lysosomal fractions, it seemed reasonable  to suppose that the reaction 
might be mediated by vasotropic  agents released from tissue mast cells which 
had been disrupted by contact with the injected lysosomal material. It was 
therefore decided to investigate the effect of PMNL lysosomes upon rat mast 
cells in vitro, in order to determine whether the lysosomal fractions employed 
in our permeability tests were, in fact, capable of rupturing these cells. 
Table  II shows the results of these  experiments.  Both lysosomal cationic 
protein (20 per cent ethanol fraction) and extracts of frozen-thawed lysosomes 
were  compared  with a  known mast  cell-rupturing agent,  compound  48/80 
(Burroughs  Wellcome and Co., Inc., Batch No. NS280). It can be seen that 
both of the lysosomal preparations  produced a marked mastocytolyfic effect 
in these  tests, although the activity of the lysosome fractions was less than 
one-tenth that of compound  48/80  when  these  agents were compared  on a A.  JANOFF,  S.  SCHAEFER,  J.  SCHERER,  AND  M.  A.  BEAN  845 
simple  weight  per  weight  basis.  However,  if  the  lysosomal cationic  protein 
was compared with compound 48/80 on a molar weight basis (see Discussion), 
then  the two agents appeared to be more nearly equal in mastocytolytic po- 
tency. 
TABLE II 
Effects  of PMNL Lysosomes  on Rat Mast Cells In Vitro 
Percentage disruption of mast cells* 
Test material  Concentration (/~g)  $  EDio§ 
0  0.4 
;ompotmd 48/80 
".P.  (lysosomal  cationic  protein,  20 
per cent ethanol fraction) 
~.P. in presence of trasylol[[ 
~.T.  (extract  of  frozen-thawed  lyso- 
somes) 
~.T. in presence of trasytolll 
28 
13 
0.2  0.3 
32  63 
21  49 
41 
66 
72 
68 
0.5  0.6 
87 
66 
45  69 
0.8  1.0 
~g #ernd 
97  0.27 
99 
92  100  3.4 
94 
100 
72  5.6 
89 
65 
C.P.  =  cationic protein fraction (20 per cent ethanol); F.T. ffi extract of frozen-thawed 
granules. 
* Percentage disruption is based on the number of mast cells showing granule extrusion 
out of 1500 cells examined  (X640). 
~g axe per ml in the case of compound  48/80 and per 0.1 ml in the case of all other 
test agents. 
§ Concentration of test agent calculated to produce 50 per cent disruption of mast cells 
(estimated from log dose/response plot). 
II Trasylol -~  zymofren (Societe  Paxisienne  d'Expansion Chimique---S.A.,  Lot No.  ES 
1402) present in a concentration of 10 kallikrein-inhibiting  units per ml. 
Preliminary evidence was also obtained which suggested that the action of 
PMNL  lysosomal cationic  protein  upon  mast  cells  was  not  simply  due  to 
the basic groups on these protein molecules, but rather may have been asso- 
ciated with some as yet unidentified, specific component of the granules, present 
only in  the  20 per  cent  ethanol-precipitated fraction  of acid extracts  of the 
lysosomes (see Discussion). 846  INFLAMMATORY  M~ECttANISM 
In view of Archer's recent report (10)  that a basic protein fraction derived 
from rat  eosinophil granules is  capable  of rupturing  rat  mast  cells  in  vitro 
and is also especially rich in peroxidase activity, the mastocytolytic fraction 
of PMNL lysosomal cationic protein was also tested for peroxidase activity in 
our experiments. Using an assay system for this enzyme based on the colori- 
metric measurement of the rate of oxidation of o-dianisidine, and possessing a 
sensitivity sufficient to  detect  0.01  ~g  of crystalline horseradish  peroxidase 
(Sigma Chemical Company, St. Louis), it nevertheless proved impossible  to 
detect any activity of this enzyme in as much as 100/zg of the cationic protein 
fraction. 
Finally, it can also be seen from the data in Table II that the mast cell- 
rupturing activity of each of the PMNL lysosomal extracts was not inhibited 
in the presence of salivary kallikrein-inhibitor, a  broad-spectrum proteolytic 
enzyme-inhibiting drug  (zymofren,  trasylol, S.A., Lot No. ES  1402, Societe 
Parisienne  d'Expansion  Chimique, Paris).  At  the  concentration of the drug 
employed  in  these tests  (see  Table II)  the protease-inhibitor produced,  by 
itself, a  slight increase in the percentage  disruption  of mast  cells  over  con- 
trol  values. 
Effect of PMNL Lysosomes  Upon  Vascular  Permeability in Rats Pretreated 
With a Mast Cell-Depleting Agent or an Antihistamine Drug.--Having made the 
observation that PMNL lysosome fractions possessed mastocytolytic activity 
in vitro and also produced vascular permeability changes in rat tissues which 
closely resembled the known vascular responses to vasotropic agents contained 
in rat mast cells, it seemed appropriate to investigate the effect of prior reduc- 
tion in numbers of mast cells or prior treatment with an antihistaminic upon 
the vascular reactions of rats to these lysosomal materials. 
In order to reduce the mast cell population in the skin, animals were given 
repeated injections of compound 48/80 according to the scheme proposed by 
Riley (11).  The agent was administered intraperitoneally twice daily in the 
following doses: 100/~g on the 1st day, 200/~g on the 2nd, 300 #g on the 3rd, 
and 400 #g on the 4th and last day. Animals were then tested 24 hours after 
the final injection of the compound. Other rats  were injected intravenously 
with the antihistamine drug chlorpheniramine maleate (Schering Corporation, 
Bloomfield, New jersey), 6 mg per 100 gm body weight, immediately before 
carrying out the permeability tests. The results of these experiments are shown 
in Table III. It can be seen that chronic pretreatment with compound 48/80 
almost  completely suppressed  the  vascular  permeability  changes  normally 
induced in skin by 10/zg of lysosomal cationic protein or by 10/~g of protein 
from frozen-thawed granules. In addition, the effects of the cationic protein 
(20 #g quantities) in the microcirculation of cremaster muscle were also blocked 
by  this  pretreatment.  Injection of  an  antihistaminic prior  to  the  test  also 
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upon vessel permeability in rat skin,  although the degree of suppression was 
slightly less pronounced than in the 48/80 pretreated group.  Cremaster tests 
were not performed in antihistamine-pretreated animals. Although not shown 
in the table, pretreatment with this antihistaminic also markedly reduced the 
permeability response in rat skin to doses of lysosomal cationic protein as large 
as 50 and 100 #g per test site. 
In  several  of  the  antihistamine-pretreated  rats,  representative  skin  sites 
were excised 40 minutes  after intracutaneous  injection  of lysosomal cationic 
TABLE III 
The Effect of Mast Call Depletion and an Antihistamine Drug upon  Vascular Permeability 
Changes in Rats Induced by PMNL Lysosomes 
None 
Chronic 48/80§ 
Pretreatment 
Single injection of chlorpheni- 
ramine maleate [I 
Lysosome fraction  * 
/~gprotein per 
test site 
c.P./m 
F.T./10 
C.P./20 
c.P./1o 
F.T./IO 
C.P./20 
c.P./lo 
F.T./10 
Test site 
Skin 
Skin 
Cremaster 
Skin 
Skin 
Cremastcr 
Skin 
Skin 
No. of 
rats 
20 
12 
6 
10 
4 
4 
10 
4 
Permeability 
response~ 
++++ 
++++ 
++ 
0to  -4- 
0to 4- 
0to 4- 
O-to+ 
+to+ 
* C.P. =  cationic protein fraction (20 per cent ethanol); F.T.  =  extract  of frozen-thawed 
granules. 
$ Permeability changes were evaluated in all animals during the  period of maximal re- 
sponse (injection of dye or carbon suspension at zero minutes). 
§ Intraperitoneal injections twice dally (doses are stated in accompanying text);  animals 
tested 24 hours after the last dose. 
II  6 mg per 100 gm body weight administered intravenously immediately prior to test. 
protein  and  were formalin-fixed and  stained  with  Harris' hematoxylin-eosin. 
This was done in order to compare the leukocyte emigration occurring in re- 
sponse to the lysosomal cationic protein (3) in normal rats with that occurring 
in  animals whose  permeability responses had  been inhibited  by the  antihis- 
tamine drug. Although the semiquantitative techniques used in this study did 
not permit a  meaningful comparison of the  degrees of inhibition  of the  two 
reactions (permeability response vs. leukotactic response), it was clear that the 
latter reaction was also partly inhibited in the skin of antihistamine-pretreated 
rats.  However, in the  rat mesentery, chlorpheniramine maleate did not sup- 848  INFL.AMMATORY  MECHANISM 
press margination of leukocytes caused by the cationic protein. This question 
is  currently undergoing  further study. 
DISCUSSION 
The foregoing observations  indicate the presence of a mastocytolytic agent 
in the lysosomes of rabbit exudate polymorphonuclear  leukocytes. This masto- 
cytolytic agent is specifically contained in PMNL granules  and is not an un- 
related cytoplasmic substance contaminating the  granule  preparation.  This 
is dearly shown by the fact that the granule-free  cytoplasmic fraction of ho- 
mogenized leukocytes possesses no demonstrable mast cell-rupturing activity, 
even when tested at protein concentrations 10 times greater than that which 
produces 50 per cent rupture of mast cells in the case of granule protein (12). 
The active principle can be extracted from PMNL granules by weak mineral 
acid and is retained in the cationic protein fraction precipitated by ethanol at 
a 20 per cent concentration. The mastocytolytic activity present in this frac- 
tion of lysosomal basic protein does not appear to be due to non-specific effects 
of positive charges. This is shown by the fact that a second basic protein frac- 
tion of the granules, precipitated from the acidified extract at 45 per cent con- 
centration of ethanol and containing more positively charged species of protein 
(as judged from electrophoretic  data), is inactive against mast cells in  vitro 
at concentrations which produce  significant  disruption of cells in the case of 
the 20 per cent ethanol fraction (12). Furthermore, neither arginine-rich  nor 
lysine-rich  preparations  of  calf-thymus histones  produce  significant  masto- 
cytolysis in vitro at concentrations  10 times greater than the ED100 concentra- 
tion of the active PMNL basic protein fraction (12). These observations  sug- 
gest that the activity present in the 20 per cent ethanol fraction of PMNL 
lysosomal cationic protein may be due to a highly specific component of this 
fraction acting  through a  mechanism independent of simple  charge  effects. 
Studies currently in progress, designed to further fractionate the active mix- 
ture of cationic  proteins,  may provide additional information concerning  this 
aspect of the problem. 
Previous  work  (3) has already shown that the active cationic protein frac- 
tion is free of a number of the hydrolytic enzymes present in crude extracts of 
PMNL lysosomes; and, in the experience of other workers  (4) such fractions 
are also devoid of catheptic activity. Moreover,  the mastocytolyfic effect of 
this material in vitro is not suppressed by a broad-spectrum  protease inhibitor 
(trasylol).  These  tests were carried  out at the highest concentration of the 
antiprotease drug which can be employed without causing damage to the mast 
cells sufficient to interfere with the assay. Unlike the experience of Archer (10) 
with mastocytolytic  basic protein obtained from eosinophil granules, the active 
PMNL fraction does not contain detectable levels of peroxidase. Earlier  work 
(3) has also shown that the active PMNL fraction is non-pyrogenic  and, on A.  ~'ANOFF,  S.  SCHAEFER,  J.  SCHERER,  AND  M.  A.  BEAN  849 
this basis, the mastocytolytic agent present in PMNL granules would not ap- 
pear  to be related to the leukocyte permeability factor ("granulocytic sub- 
stance") described  by Moses and coworkers (13). 
Frimmer has recently extended his studies  on the  general  mechanism of 
action of nuclear histones  and basic polypeptides  upon vascular permeability 
to include  investigations  of artificial  membrane systems (14). He suggests  a 
mechanism of altered permeability in his membrane system based on physico- 
chemical  changes  in  acid-mucopolysaccharides  caused  by  their  interaction 
with basic protein. Thus, there may be additional modes of action of PMNL 
lysosomal cationic proteins upon vessel wall permeability in vivo  in addition 
to the indirect effect mediated through mast cell degranulation. It should be 
noted that the permeability-enhancing  lysosomal cationic protein fraction was 
tested by us for acld-mucopolysaccharases and was found to be free of measur- 
able  chondroitin  sulfatase  and  hyaluronidase  activity  (turbidity-reduction 
assay method of Tolksdorf et al.  (15), modified after Kass and Seastone (16)). 
The data presented in this paper show that the cationic protein is less active 
than compound 48/80 when the two are compared on a weight per weight basis. 
Until the PMNL factor is identified and characterized  it will not be possible 
to accurately compare  its potency with that of compound 48/80  on a molar 
weight basis, but reasonable estimates can be made on the grounds of presently 
available  facts. Since the mastocytolytic principle  of PMNL granules  is not 
dialyzable (see Materials and Methods) it can be assumed to possess a molecu- 
lar weight of at least 10,000. On the other hand, the molecular weight of the 
active form of compound 48/80 is known. It has been reported (17) that the 
trimer (mol wt =  about 500) and tetramer (mol wt =  about 650) forms of the 
compound are active, while polymers of the pentamer class or higher are in- 
active.  Thus, if the two mastocytolytic principles  are compared  on the basis 
of estimated molar weights, the PMNL principle is highly active with reference 
to compound 48/80. 
In conclusion, while these  studies do not exclude the possible role of lyso- 
somal acid proteases  in terminal phases  of necrotizing  tissue injury reactions 
such as  the Arthus reaction (1,  2)  or the dermal Shwartzman reaction (18, 
19), the present studies do show that the early phase of vascular injury induced 
in rat tissues by extracts of frozen-thawed  PMNL lysosomes, or by certain of 
the cationic  proteins isolated from these granules,  is mediated by vasotropic 
agents released from disrupted mast cells rather than by proteases  present in 
the leukocyte granules  themselves.  It therefore  seems reasonable  to suggest 
that  PMN  leukocytes entering perivascular  tissue  spaces  during naturally- 
occurring  tissue  injury reactions,  release  their lysosomal  granules  and  that 
these,  in turn, may affect local mast cells in a manner analogous to that de- 
scribed in the in vitro studies reported here.  Such a reaction would constitute 850  IIWELAMMATOR¥  MECHANISM 
a distinct mechanism by which leukocyte lysosomes play a part in the patho- 
genesis of inflammation. 
SUMMARY 
The vascular permeability-increasing action of rabbit PMNL lysosomes has 
been studied in skin and cremaster muscle of the rat. 
Both  an  extract  of  frozen-thawed granules  and  a  cathepsin-free cationic 
protein fraction of the granules (which had previously been demonstrated to 
cause leukocyte adhesion  and  emigration in  vivo)  induce  increased vascular 
permeability in skin and muscle which resembles that produced by histamine 
or histamine-liberators with respect to the timing of the response and the pre- 
dominant type of microvessel affected. 
Extracts of frozen-thawed lysosomes and the inflammatory lysosomal cationic 
protein both cause disruption of rat mesenteric mast cells in vitro,  whereas a 
granule-free cytoplasmic fraction of PMN leukocytes and a non-inflammatory 
cationic protein fraction of the granules do not do so under identical test con- 
ditions. The mastocytolytic action of lysosomal  materials  in  vitro  is  not  in- 
hibited in the presence of 10 kaUikrein-inhibiting units of trasylol per mi. The 
mast  cell rupturing  fraction of PMNL  granules  (cationic protein) possesses 
no detectable peroxidase activity or acid-mucopolysaccharase activity. When 
compared with compound 48/80 on the basis  of estimated molecular weight, 
the lysosomal cationic protein appears  to be at least as  active as  the latter 
compound with respect to in  vitro mastocytolytic potency. 
Chronic pretreatment of rats  with  an agent known to reduce tissue mast 
cell numbers causes marked suppression of the vascular  permeability change 
normally induced in skin and muscle by lysosomal extracts and cationic pro- 
tein.  Similar  results  are  obtained  if  lysosomal  materials  are  tested  in  rats 
pretreated with an antihistaminic. 
These observations are discussed with respect to the mode of action of PMNL 
lysosomes in the early and late phases of local tissue-injury reactions. 
The authors wish to express their indebtedness to Dr. Benjamin W. Zweifach,  whose sug- 
gestions at the outset of this work and whose helpful criticisms during its subsequent course 
of development provided an invaluable assistance. 
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